NasdaqGM:CMRC
NasdaqGM:CMRCIT

3 Promising Penny Stocks With Market Caps Under $2B

As the Dow Jones Industrial Average reaches an all-time high, investors are keenly watching for opportunities amid mixed performances in major indices. In this context, penny stocks—often representing smaller or newer companies—remain a compelling area of interest due to their potential for growth at lower price points. Despite being considered a niche investment, these stocks can offer significant upside when backed by strong financial health and solid fundamentals.
NasdaqCM:SUIG
NasdaqCM:SUIGDiversified Financial

Undiscovered US Gems To Explore In August 2025

As the Dow Jones Industrial Average reaches an all-time high and major indices like the S&P 500 and Nasdaq experience slight declines, investors are keenly observing market trends amid expectations of potential interest rate cuts by the Federal Reserve. In this dynamic environment, identifying promising investments often involves looking beyond well-known large-cap stocks to discover smaller companies with strong fundamentals and growth potential that may offer unique opportunities in a...
NYSE:CTRE
NYSE:CTREHealth Care REITs

3 Top Dividend Stocks To Consider For Your Portfolio

In a dynamic market environment where the Dow Jones Industrial Average has reached an all-time high while the S&P 500 and Nasdaq have experienced slight declines, investors are keenly observing potential interest rate cuts by the Federal Reserve. Amidst these mixed signals, dividend stocks can offer a reliable income stream and stability, making them an attractive consideration for portfolios in times of economic uncertainty.
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Why Ardelyx (ARDX) Is Up 10.6% After Raising IBSRELA Sales Outlook and Reporting Strong Q2 Revenue

Earlier this month, Ardelyx, Inc. announced the adoption of updated company bylaws, key executive appointments, and reported strong second-quarter financial results, including a rise in revenue to US$97.66 million and increased full-year net sales guidance for IBSRELA. An interesting aspect is that Ardelyx not only grew sales but also raised revenue expectations for its lead therapy, signaling confidence in ongoing product performance despite continued net losses and pending CFO...
NYSE:HCA
NYSE:HCAHealthcare

How the Antitrust Lawsuit Settlement at HCA Healthcare (HCA) Has Changed Its Investment Story

HCA Healthcare and its subsidiary Mission Health recently settled a federal antitrust lawsuit with local governments in Western North Carolina, agreeing to donate US$1 million to a new charity care fund and keep a regional hospital open for three additional years. This resolution addresses a legal dispute that had persisted since HCA’s acquisition of Mission Health in 2019, removing a major source of uncertainty for the company. We'll explore how closing this antitrust case could influence...
NYSE:PARR
NYSE:PARROil and Gas

Par Pacific Holdings (PARR) Is Up 6.5% After Earnings Beat and Major Share Buyback

Par Pacific Holdings, Inc. recently reported second quarter 2025 earnings, noting net income of US$59.46 million and basic earnings per share of US$1.18, despite sales declining to US$1.89 billion compared to a year ago. The company also completed a major share buyback during the quarter, reducing its share count by 8.58% and signaling a focus on shareholder value amid improved profitability. With these results underscoring both improved net income and capital returns, we’ll now consider...